Colorectal Cancer News

UK Study Reveals Low-Dose Aspirin Lowers Colon Cancer Risk

Low doses of aspirin, often taken to reduce the risk of heart attack and strokes, have been found to reduce the risk of colon cancer, as well.

British researchers found that aspirin reduced the number of cases of colorectal cancer by one-fourth and cut colon cancer deaths by one-third.

The study shows that lower doses of aspirin are much more effective and safer than larger doses are reducing the risk.

“This interesting study would incite clinicians to turn to primary prevention of colorectal cancer by aspirin at least in high risk-populations. Specific guidelines for aspirin chemoprevention would be the next logical step,” Dr. Robert Benamouzig and Dr. Bernard Uzzan of Avicenne Hospital in Bobigny, France, wrote in a commentary.

References
Low-dose aspirin lowers colon cancer risk. Reuters. 2010 October 21.

Return